Merck (MRK) ASCO Presentations Drive KEYTRUDA Model Revisions - RBC Capital
Tweet Send to a Friend
RBC Capital analyst Randall Stanicky reiterated a Sector Perform rating and $84.00 price target on Merck (NYSE: MRK) after attending ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
